The rise of personalised and highly complex drug product profiles necessitates significant
advancements in pharmaceutical manufacturing and distribution. Efforts to develop more …

Advanced Therapy Medicinal Products (ATMPs) are a novel class of biological therapeutics
that utilise ground-breaking clinical interventions to prevent and treat life-threatening …

This work proposes an agent-based model for cost-effectiveness analysis in the
manufacture of allogeneic human induced pluripotent (hiPS) cells in Japan. The agent …

Personalised medicine (PM) is a new area of healthcare that has shown promising results in
offering treatments for rare and advanced stage diseases. Nonetheless, their supply chain …

With almost 50% of annual commercial drug approvals being Personalised Medicine (PM)
and its huge potential to improve quality of life, this emerging medical sector has received …

The rise of personalised and highly complex drug product profiles necessitates significant
advancements in pharmaceutical manufacturing and distribution. Efforts to develop more …

Abstract Chimeric Antigen Receptor (CAR) T-cell therapies are cellular immunotherapies
that displayed encouraging results in the treatment of blood cancer types like acute …

Currently, personalized medicine drugs have better therapeutic outcomes, but their large-
scale delivery remains a challenge. With the changing social environment, supply chain …

Personalised medicine (PM) refers to treatment plans tailored for specific sub-populations
and individuals by considering environmental, genetic, and social factors. The PM field has …